Accelerating Your Cell & Gene Therapy and Biologics Programs: A Strategic Approach to Nonclinical & Early Phase Development

Bringing innovative cell and gene therapies or biologics to patients requires meticulous planning and execution, and the journey begins in the crucial nonclinical and early phase development stages. At TKD Solutions, we understand that a strategic approach to these early steps is paramount, not just for scientific advancement, but for streamlining your future path to regulatory approval.

The Foundation: Strategic Nonclinical Development for IND Success

The journey towards an Investigational New Drug (IND) application begins long before the submission itself. Our nonclinical development efforts are precisely designed to anticipate and meet IND specifications. By focusing on early phase studies, we proactively address potential questions from regulatory authorities, allowing us to prescribe and execute IND-enabling studies with end-goal precision. This rigorous approach de-risks your program early on, providing the critical data needed for informed decision-making in subsequent process development and clinical study design.

We proactively address potential questions from regulatory authorities, allowing us to prescribe and execute IND-enabling studies with end-goal precision

Comprehensive Services for
De-Risking Your Program

TKD Solutions offers a comprehensive suite of services tailored to guide your program through the complexities of early development:

• Lead Candidate Selection & Optimization: Identifying and refining the most promising candidates to maximize therapeutic potential.
• Study Design: Crafting robust and efficient study protocols for both efficacy and safety assessments.
• Gap Analysis: Identifying and addressing any data gaps to strengthen your regulatory submissions.
• Efficacy & Safety Studies: Designing and overseeing studies to demonstrate the therapeutic effect and safety profile of your product.
• Toxicology: Conducting thorough toxicological assessments to understand potential adverse effects.
• Regulatory Support: Providing expert guidance and support throughout the regulatory submission process, leveraging our experience to navigate the path to IND approvals.

Specialized Expertise for Cell & Gene Therapies and Biologics

Different modalities pose unique challenges in nonclinical development, and our consultative approach is rooted in your specific modality and target disease:

• For Cell & Gene Therapies: We adopt a holistic approach, meticulously designing an effective therapy that contemplates the interplay of disease pathobiology, optimal delivery method, and vector design.
• For Biologics: Our expertise includes the development of comprehensive mechanism of action studies and precise drug repurposing study designs – even unlocking new potential for existing molecules.

TKD Solutions: Your Nonclinical Team, Extended

Leveraging our deep experience in advancing early-stage programs, you can trust TKD Solutions to help navigate the complexities of nonclinical and early phase development. Our strategic, data-driven approach is designed to streamline your path to IND approvals, accelerating the delivery of life-changing therapies to patients.

Download our Infographic to see how we can plug in to become an extension of your internal nonclinical team.